Rebastinib

Rebastinib
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T2640-2mg 2 mg

7 - 10 business days*

39.00€
TGM-T2640-5mg 5 mg

7 - 10 business days*

59.00€
TGM-T2640-10mg 10 mg

7 - 10 business days*

91.00€
TGM-T2640-25mg 25 mg

7 - 10 business days*

170.00€
TGM-T2640-50mg 50 mg

7 - 10 business days*

250.00€
TGM-T2640-100mg 100 mg

7 - 10 business days*

375.00€
TGM-T2640-200mg 200 mg

7 - 10 business days*

564.00€
 
Description: DCC-2036 (Rebastinib (DCC-2036)) is a conformational control Bcr-Abl inhibitor for... more
Product information "Rebastinib"
Description: DCC-2036 (Rebastinib (DCC-2036)) is a conformational control Bcr-Abl inhibitor for Abl1(WT, IC50: 0.8 nM) and Abl1(T315I, IC50: 4 nM), also inhibits LYN, SRC, HCK, FGR, FLT3, KDR, and Tie-2, and low activity to c-Kit. Rebastinib aimed at the Angiopoietin2-Tie2 pathway. Target: FLT, Apoptosis, Bcr-Abl, Src. Smiles: CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(nn3-c3ccc4ncccc4c3)C(C)(C)C)c(F)c2)ccn1. References: Chan WW, et al. Cancer Cell. 2011, 19(4), 556-568.
Keywords: DCC2036, DCC 2036, DCC-2036
Supplier: TargetMol
Supplier-Nr: T2640

Properties

MW: 553.59 D
Formula: C30H28FN7O3
Format: 32160405

Database Information

CAS : 1020172-07-9| Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Rebastinib"
Write a review
or to review a product.
Viewed